By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Southwest Oncology Group 

1100 Fairview Ave N, MP-557
PO Box 19204
Seattle  Washington  98109-1024  U.S.A.
Phone: 206-667-4623 Fax: 206-667-4408


Medical Device

Company News
Why Are African-Americans Less Likely To Survive Certain Cancers?, Southwest Oncology Group Study 7/8/2009 7:41:08 AM
Southwest Oncology Group Phase III Newly Diagnosed Multiple Myeloma Trial (S0232) Closed and Patients Given Choice to Switch to REVLIMID(R) Plus Dexamethasone 5/16/2007 11:06:06 AM
Oxford BioMedica PLC (OXB.L) Release: Southwest Oncology Group To Start A Phase II Trail Of Trovax In Breast Cancer 9/7/2006 2:42:36 PM
CuraGen Corporation (CRGN) And TopoTarget A/S Announce Southwest Oncology Group Opens New Lymphoma Trial With PXD101 8/24/2006 9:37:57 AM
Cancer and Leukemia Group B And Southwest Oncology Group To Evaluate The Addition Of Erbitux To Chemotherapy Or Chemotherapy And Avastin In First-Line Metastatic Colorectal Cancer10/19/2005 5:12:55 PM
Southwest Oncology Group's Prostate Cancer Study Featured In The New England Journal of Medicine10/19/2005 5:11:46 PM
Southwest Oncology Group Trial Shows That Taxotere(R) Significantly Improves Survival In Men With Prostate Cancer10/19/2005 5:11:40 PM
Southwest Oncology Group Initiates Phase 2 Clinical Trial Using Introgen Therapeutics, Inc.'s (INGN) Advexin Cancer Therapy10/19/2005 5:10:59 PM
Southwest Oncology Group Release: Study Findings Show The Longest Reported Survival Rate For Patients With Locally Advanced Lung Cancer10/19/2005 5:10:05 PM
Introgen Therapeutics, Inc.'s (INGN) Advexin Therapy To Be Combined With Surgery In Phase II Trial; Introgen And Southwest Oncology Group Enter Agreement For Clinical Testing10/19/2005 5:09:17 PM